The role of RBM10 mutations in the development, treatment, and prognosis of lung adenocarcinoma

RBM10 is the RNA-binding protein often absent or mutated in lung adenocarcinoma, rendering it as a potential biomarker or even therapeutic target to prolongate survival time. In this study, we investigated the involvement of RBM10 mutation in the pathogenesis and tumorigenesis of lung adenocarcinoma...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Cell Cycle
Päätekijät: Li, Zhenqing, Xue, Qun, Xu, Jianxun, Zhang, Pengfei, Ding, Bo
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Taylor & Francis 2020
Aiheet:
Research Paper
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC7714495/
https://ncbi.nlm.nih.gov/pubmed/33064970
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/15384101.2020.1829801
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia